JohnAlanGrayMDPhD

PubMed

• 522 citations
  Psychedelics Promote Structural and Functional Neural Plasticity
  Calvin Ly, Alexandra C. Greb, Lindsay P. Cameron, Jonathan M. Wong, Eden V. Barragan
  Cell Reports. 2018-06-12
• 31 citations
  5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines.
  Lindsay P Cameron, Seona D Patel, Maxemiliano V Vargas, Eden V Barragan, Hannah N Saeger
  ACS Chemical Neuroscience. 2023-02-01
• 283 citations
  Metabolic control of vesicular glutamate transport and release.
  Narinobu Juge, John A. Gray, Hiroshi Omote, Takaaki Miyaji, Tsuyoshi Inoue
  Neuron. 2010-10-06

Journal Articles

• When clozapine is not enough. Augment with lamotrigine?  
  Gray JA, Risch SC, Current Psychiatry
• Developing selectively non-selective drugs for treating CNS disorders.  
  Gray JA, Roth BL, Drug Discovery Today: Therapeutic Strategies

Books/Book Chapters

• Kaplan & Sadock’s Comprehensive Textbook of Psychiatry 
  Chapter: Intraneuronal Signaling 
  Page 118 - 129Gray JA, Roth BLEditors: Sadock BJ, Sadock VA, Ruiz P.Lippincott Williams & Wilkins, Philadelphia
• Handbook of Contemporary Neuropharmacology 
  Chapter: Serotonin Systems 
  Page 257 - 298Gray JA, Roth BLEditors: Sibley DR, Hanin I, Kuhar M, Skolnick P.John Wiley & Sons, New York
• Basic and Clinical Pharmacology 
  Chapter: Introduction to the Pharmacology of CNS Drugs 
  Page 355 - 368Gray JA, Nicoll RAEditors: Katzung BG.McGraw-Hill, New York, NY2014
• Ferri’s Clinical Advisor 2013 
  Chapter: Tardive Dyskinesia 
  Gray JAEditors: Ferri FF.Mosbi, PhiladelphiaEdition 2013,
• Ferri’s Clinical Advisor 2012 
  Chapter: Tardive Dyskinesia 
  Gray JAEditors: Ferri FF.Mosbi, PhiladelphiaEdition 2012,
• Ferri’s Clinical Advisor 2011 
  Chapter: Tardive Dyskinesia 
  Page 1069 - 1070Gray JAEditors: Ferri FF.Mosbi, PhiladelphiaEdition 2011,
• Ferri’s Clinical Advisor 2010 
  Chapter: Tardive Dyskinesia 
  Gray JA, Lai AEditors: Ferri FF.Mosbi, PhiladelphiaEdition 2010,
• Join now to see all

Abstracts/Posters

• Novel molecular replacement strategy for dissecting synaptic and extrasynaptic NMDA receptor targeting.
  Gray JA, Sanz-Clemente A, Roche KW, Nicoll RA, Federation of European Neuroscience Societies Annual Meeting, Barcelona, Spain
• CaMKII binding to GluN2B controls synaptic NMDAR composition by facilitating the phosphorylation of the GluN2B PDZ ligand
  Sanz-Clemente A, Gray JA, Ogilvie KA, Nicoll RA, Roche KW, for Neuroscience, New Orleans, LA
• Distinct modes of AMPA receptor suppression at developing synapses by the NMDA receptor subunits GluN2A and GluN2B.
  Gray JA, Usui H, During MJ, Sakimura K, Nicoll RA, Society for Neuroscience, Washington DC
• Designing a neuroscience curriculum based upon constructivist learning principles.
  Rose DA, Gray JA, Association for Academic Psychiatry, Santa Fe, NM
• A constitutively active arrestin rescues arrestin-insensitivity of the 5-HT2A receptor and induces agonist-independent internalization.
  Gray JA, Bhatnagar A, Gurevich VV, Roth BL, Great Lakes GPCR Retreat, Ann Arbor, MI
• Cell-type specific role of endocytosis in 5-HT2A receptor desensitization and resensitization: Arrestin-independent regulation in HEK-293 cells is unrelated to the le...
  Gray JA, Sheffler DJ, Kroeze WK, Roth BL, Society for Neuroscience, San Diego, CA
• Novel techniques for probing receptor-G-protein interactions: G-protein affinity chromatography and i3-ELISA.
  Hyde EG, Gray JA, Gelber EI, Kroeze WK, Roth BL, Society for Neuroscience, San Diego, CA
• Join now to see all